NO179327C - Fremgangsmåte for fremstilling av et preparat omfattende Cohn's V. fraksjon - Google Patents

Fremgangsmåte for fremstilling av et preparat omfattende Cohn's V. fraksjon

Info

Publication number
NO179327C
NO179327C NO893194A NO893194A NO179327C NO 179327 C NO179327 C NO 179327C NO 893194 A NO893194 A NO 893194A NO 893194 A NO893194 A NO 893194A NO 179327 C NO179327 C NO 179327C
Authority
NO
Norway
Prior art keywords
cohn
mammal
abdominal cavity
fraction
ascites
Prior art date
Application number
NO893194A
Other languages
English (en)
Norwegian (no)
Other versions
NO179327B (no
NO893194D0 (no
NO893194L (no
Inventor
Ichiei Sato
Original Assignee
Bio Defence Inst Co Ltd
Kanto Ishi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Defence Inst Co Ltd, Kanto Ishi Pharma Co Ltd filed Critical Bio Defence Inst Co Ltd
Publication of NO893194D0 publication Critical patent/NO893194D0/no
Publication of NO893194L publication Critical patent/NO893194L/no
Publication of NO179327B publication Critical patent/NO179327B/no
Publication of NO179327C publication Critical patent/NO179327C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO893194A 1988-08-10 1989-08-08 Fremgangsmåte for fremstilling av et preparat omfattende Cohn's V. fraksjon NO179327C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63199688A JPH0688906B2 (ja) 1988-08-10 1988-08-10 制癌作用を有する生物活性物質の製造方法およびそれにより得られる制癌作用を有する生物活性物質

Publications (4)

Publication Number Publication Date
NO893194D0 NO893194D0 (no) 1989-08-08
NO893194L NO893194L (no) 1990-02-12
NO179327B NO179327B (no) 1996-06-10
NO179327C true NO179327C (no) 1996-09-18

Family

ID=16411959

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893194A NO179327C (no) 1988-08-10 1989-08-08 Fremgangsmåte for fremstilling av et preparat omfattende Cohn's V. fraksjon

Country Status (15)

Country Link
EP (1) EP0354492B1 (de)
JP (1) JPH0688906B2 (de)
KR (1) KR940003053B1 (de)
AT (1) ATE110733T1 (de)
AU (1) AU616548B2 (de)
CA (1) CA1326996C (de)
DE (1) DE68917830T2 (de)
DK (1) DK386689A (de)
ES (1) ES2059656T3 (de)
FI (1) FI100457B (de)
HK (1) HK1005190A1 (de)
HU (1) HU205257B (de)
IL (1) IL91251A (de)
NO (1) NO179327C (de)
NZ (1) NZ230250A (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
JPS57140725A (en) * 1981-12-28 1982-08-31 Dainippon Pharmaceut Co Ltd Physiologically active substance having carcinostatic action
JPS58141785A (ja) * 1982-02-16 1983-08-23 Nippon Shinyaku Co Ltd 抗腫瘍物質の製法
JPS6256430A (ja) * 1985-09-04 1987-03-12 Takeda Chem Ind Ltd 抗腫瘍性酸性糖蛋白

Also Published As

Publication number Publication date
FI100457B (fi) 1997-12-15
HU205257B (en) 1992-04-28
DK386689D0 (da) 1989-08-07
IL91251A0 (en) 1990-03-19
KR900002790A (ko) 1990-03-23
AU616548B2 (en) 1991-10-31
JPH0688906B2 (ja) 1994-11-09
NZ230250A (en) 1992-09-25
KR940003053B1 (ko) 1994-04-13
EP0354492A3 (en) 1990-08-01
EP0354492A2 (de) 1990-02-14
NO179327B (no) 1996-06-10
ES2059656T3 (es) 1994-11-16
DK386689A (da) 1990-02-11
HUT53808A (en) 1990-12-28
IL91251A (en) 1994-12-29
EP0354492B1 (de) 1994-08-31
DE68917830T2 (de) 1994-12-22
FI893765L (fi) 1990-02-11
ATE110733T1 (de) 1994-09-15
HK1005190A1 (en) 1998-12-24
FI893765A0 (fi) 1989-08-09
AU3936589A (en) 1990-02-15
JPH0248532A (ja) 1990-02-19
NO893194D0 (no) 1989-08-08
NO893194L (no) 1990-02-12
CA1326996C (en) 1994-02-15
DE68917830D1 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
DE69433013D1 (de) Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
SG43037A1 (en) New esters of bi-and tricyclic aminoalcohols their preparation and their use in pharmaceutical compositions
ES2171933T3 (es) Derivados de androsteno.
DE3886175T2 (de) Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt.
DE3267294D1 (en) Pyridazinone derivatives, their preparation and their use in agricultural compositions and the treatment of seed and plants
NO179327C (no) Fremgangsmåte for fremstilling av et preparat omfattende Cohn's V. fraksjon
Marotti et al. In vivo effect of progesteron and estrogen on thymus mass and T-cell functions in female mice
Thompson et al. Preliminary study of potential antiarrhythmic effects of Crataegus monogyna
Doody et al. Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts.
Uhlenbruck et al. An incomplete anti-B agglutinin in the eggs of the prosobranch snail Pila ovata
Izzo et al. Preferential localization and rate of loss of labeled alloantibody from rat tumors and skin transplants carrying the corresponding alloantigen
DE4312916C2 (de) Arzneimittel zur Behandlung von Immunreaktionen
DE4345200C2 (de) Hybridomzellen, die Antikörper bilden, die als Wirkstoff in Arzneimitteln zur Behandlung von Immunreaktionen enthalten sind
Naruse et al. Selective glomerular thrombosis in rats induced by combined injections of nephrotoxic antiserum and lipopolysaccharide
DE69919969D1 (de) Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
NO880663D0 (no) Fremgangsmaate for aa oeke effektiviteten av in vitro vegetativ formering av poteter.
EP0505414A1 (de) Eliminierung von aktivierten lymphozyten.
Kowalewski et al. Effect of antrectomy on the response of stomach to histamine and pentagastrin in rats
EP0169895A1 (de) Medizinische pflanzenzusammensetzung zur behandlung bestimmter leber- und gallenkrankheiten.
Marrangoni et al. Vascular grafts in microvascular surgery: An experimental study
Rogo A case of mysterious stone-throwing in Arizona.
Remgård et al. Regenerating Peripheral Axons Transport and Release Low‐Molecular‐Mass Materials In Vitro
Manabe et al. Heterotransplantation of the cultured cell from a human giant cell tumour of bone
Godfrey Mechanism of formation of non-immune rosettes between guinea-pig thymus-derived lymphocytes and rabbit erythrocytes
ITMI910133A1 (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono